Belimumab as Add-on Therapy in Lupus Nephritis
- PMID: 32937052
- DOI: 10.1056/NEJMe2027516
Belimumab as Add-on Therapy in Lupus Nephritis
Comment on
-
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.N Engl J Med. 2020 Sep 17;383(12):1117-1128. doi: 10.1056/NEJMoa2001180. N Engl J Med. 2020. PMID: 32937045 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources